JSL
UTHR icon

JT Stratford LLC’s United Therapeutics UTHR Stock Holding History

JT Stratford LLC’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534K Buy
985
+4
+0.4% +$2.25K 0.06% 213
2026
Q1 		$582K Sell
981
-43
-4% -$21.4K 0.07% 197
2025
Q4 		$499K Buy
+1,024
New +$477K 0.06% 216

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

JT Stratford LLC's UTHR Position: Q2 2026 in Review

JT Stratford LLC increased its United Therapeutics (UTHR) stake by 0.41% in Q2 2026, buying an estimated $2.25K and bringing the position to 985 shares worth $534K. The position accounts for 0.06% of the portfolio, ranked #213.

JT Stratford LLC first reported a position in UTHR in Q4 2025 and has held it in 3 quarters since. The position peaked at $582K in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • JT Stratford LLC held 985 shares of United Therapeutics worth $534K as of Q2 2026.
  • JT Stratford LLC bought 4 United Therapeutics shares in Q2 2026, an estimated $2.25K.
  • United Therapeutics made up 0.06% of JT Stratford LLC's portfolio in Q2 2026, its #213 holding.
  • JT Stratford LLC first reported a position in United Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • JT Stratford LLC's United Therapeutics position peaked at $582K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on JT Stratford LLC's 13F filing for Q2 2026, filed 14 Aug 2026.